What can I claim secondary to vaccine-induced thrombotic thrombocytopaenia?
1 condition in the Repatriation Medical Authority's Statements of Principles list vaccine-induced thrombotic thrombocytopaenia as a factor. If DVA has accepted your vaccine-induced thrombotic thrombocytopaenia, each of these has a documented pathway to a further claim.
At a glance
- Accepted conditionVaccine-induced thrombotic thrombocytopaenia
- Conditions it may open1
- SourceRMA SoPs
- Chart Review$600 + GST
How a secondary claim works
Some Statement of Principles factors are not about service at all — they name another condition. Where DVA has already accepted your vaccine-induced thrombotic thrombocytopaenia, and another condition's SoP lists vaccine-induced thrombotic thrombocytopaenia as a factor, that part of the next claim is already established on your file. How a secondary claim works, in full →
Conditions that list vaccine-induced thrombotic thrombocytopaenia as a factor
Quoted from the instrument. A pathway existing is not the same as a claim succeeding — each factor carries thresholds your record has to satisfy.
Cerebrovascular accident (stroke)
RH No. 45 of 2024 · BoP No. 46 of 2024
Reasonable Hypothesis — factor (14): “having thrombotic thrombocytopaenic purpura, sickle cell disorder or vaccine-induced thrombotic thrombocytopaenia at the time of clinical onset” [clinical onset]
Balance of Probabilities — factor (13): “having thrombotic thrombocytopaenic purpura, sickle cell disorder or vaccine-induced thrombotic thrombocytopaenia at the time of clinical onset” [clinical onset]
Other accepted conditions that also open cerebrovascular accident (stroke)
If any of these is also on your file, it reaches some of the same conditions vaccine-induced thrombotic thrombocytopaenia does.
What DVA means by vaccine-induced thrombotic thrombocytopaenia
A claim is tested against the definition first. If the diagnosis on your file does not meet this wording, the factors below never get reached — so it is worth checking that what your doctor wrote matches what the instrument requires.
Vaccine-induced thrombotic thrombocytopaenia, for the purposes of the Statement of Principles, for the purposes of this Statement of Principles, vaccine-induced thrombotic thrombocytopaenia means a disorder of coagulation in which there is formation of blood clots in the vascular system in association with a low platelet count, in a person with no exposure to heparin within the previous 30 days.
RH No. 33 of 2022 · BoP No. 34 of 2022 · 2 factors
Every factor in the vaccine-induced thrombotic thrombocytopaenia SoP →
What could support a claim for vaccine-induced thrombotic thrombocytopaenia?
The Statement of Principles for vaccine-induced thrombotic thrombocytopaenia names 1 other condition among its own factors. If any of these is already accepted on your file, it may be the factor that carries a vaccine-induced thrombotic thrombocytopaenia claim — quoted here from the instrument.
Coronavirus disease 2019 (covid-19)
Reasonable Hypothesis — factor (1): “having received an adenovirus vector coronavirus disease 2019 (COVID-19) vaccine within the 100 days before the clinical onset of vaccine-induced thrombotic thrombocytopaenia; (a) Ad26.COV2.S (Janssen COVID-19 Vaccine); (b) ChAdOx1 nCoV-19 (Vaxevria, Oxford/Astra-Zeneca); (c) Gam-COVID-Vac (Sputnik V, Sputnik Light); and (d) AD5-nCOV (Convidecia)” [clinical onset]
Balance of Probabilities — factor (1): “having received an adenovirus vector coronavirus disease 2019 (COVID-19) vaccine within the 100 days before the clinical onset of vaccine-induced thrombotic thrombocytopaenia; (a) Ad26.COV2.S (Janssen COVID-19 Vaccine); (b) ChAdOx1 nCoV-19 (Vaxevria, Oxford/Astra-Zeneca); (c) Gam-COVID-Vac (Sputnik V, Sputnik Light); and (d) AD5-nCOV (Convidecia)” [clinical onset]
Reviewed by Dr Thomas Perkins
Founding doctor, Veterans Health Centre · former RAAF aviation medical officer · 13 years working exclusively with ADF members and veterans. Full profile →
Vaccine-induced thrombotic thrombocytopaenia accepted?
Contact us for more information.